Repressed experiments for module 429

Experiment nameClinical attributes
Alizadeh00_DLCL_0005_lc4b064Lymphoma or lymphoma cell line (B lymphoma), Lymphocytes (B lymphoma*), Hematologic cancer and cell line (B lymphoma*), Cancer and cell line (B lymphoma*), B cells (B lymphoma*), Diffuse large B cell lymphoma tumor or cell line (B lymphoma), Hematologic cancer (B lymphoma*), Cancer (B lymphoma*), Diffuse large B cell lymphoma - DLBCL (B lymphoma), Activated B like DLBCL (B lymphoma)
Alizadeh00_DLCL_0035Lymphoma or lymphoma cell line (B lymphoma), Lymphocytes (B lymphoma*), Hematologic cancer and cell line (B lymphoma*), Cancer and cell line (B lymphoma*), B cells (B lymphoma*), Diffuse large B cell lymphoma tumor or cell line (B lymphoma), Hematologic cancer (B lymphoma*), Cancer (B lymphoma*), Diffuse large B cell lymphoma - DLBCL (B lymphoma)
Alizadeh00_DLCL_0035_lc4b035Lymphoma or lymphoma cell line (B lymphoma), Lymphocytes (B lymphoma*), Hematologic cancer and cell line (B lymphoma*), Cancer and cell line (B lymphoma*), B cells (B lymphoma*), Diffuse large B cell lymphoma tumor or cell line (B lymphoma), Hematologic cancer (B lymphoma*), Cancer (B lymphoma*), Diffuse large B cell lymphoma - DLBCL (B lymphoma)
Chen02_Liver_HBV_SF32Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), Non-tumor liver tissue (Liver cancer)
Rosenwald01_CLL_16Lymphocytes (B lymphoma*), Hematologic cancer and cell line (B lymphoma*), Cancer and cell line (B lymphoma*), B cells (B lymphoma*), Hematologic cancer (B lymphoma*), Cancer (B lymphoma*), Chronic lymphocytic leukemia (B lymphoma), Leukemia (B lymphoma), Leukemia or leukemia cell line (B lymphoma)
Singh02_N02__normalNormal prostate tissue (Prostate cancer), Normal tissue (Prostate cancer), Prostate (Prostate cancer*)
Singh02_N11__normalNormal prostate tissue (Prostate cancer), Normal tissue (Prostate cancer), Prostate (Prostate cancer*)
Singh02_N13__normalNormal prostate tissue (Prostate cancer), Normal tissue (Prostate cancer), Prostate (Prostate cancer*)
Singh02_N17__normalNormal prostate tissue (Prostate cancer), Normal tissue (Prostate cancer), Prostate (Prostate cancer*)
Singh02_N19__normalNormal prostate tissue (Prostate cancer), Normal tissue (Prostate cancer), Prostate (Prostate cancer*)
Singh02_N20__normalNormal prostate tissue (Prostate cancer), Normal tissue (Prostate cancer), Prostate (Prostate cancer*)
Singh02_N23__normalNormal prostate tissue (Prostate cancer), Normal tissue (Prostate cancer), Prostate (Prostate cancer*)
Singh02_N26__normalNormal prostate tissue (Prostate cancer), Normal tissue (Prostate cancer), Prostate (Prostate cancer*)
Singh02_N35__normalNormal prostate tissue (Prostate cancer), Normal tissue (Prostate cancer), Prostate (Prostate cancer*)
Singh02_N50__normalNormal prostate tissue (Prostate cancer), Normal tissue (Prostate cancer), Prostate (Prostate cancer*)
Singh02_T21__tumorProstate (Prostate cancer*), Prostate cancer (Prostate cancer), Prostate cancer or cell line (Prostate cancer), Cancer and cell line (Prostate cancer), Cancer (Prostate cancer), Adenocarcinoma (Prostate cancer)
Singh02_T34__tumorProstate (Prostate cancer*), Prostate cancer (Prostate cancer), Prostate cancer or cell line (Prostate cancer), Cancer and cell line (Prostate cancer), Cancer (Prostate cancer), Adenocarcinoma (Prostate cancer)
Singh02_T49__tumorProstate (Prostate cancer*), Prostate cancer (Prostate cancer), Prostate cancer or cell line (Prostate cancer), Cancer and cell line (Prostate cancer), Cancer (Prostate cancer), Adenocarcinoma (Prostate cancer)
Sorlie01_BC205B_AFBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Dead prognosis (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer)
Sorlie01_BC303B_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Grade 3 (Breast cancer), Mutated p53 tumor (Breast cancer)
Whitfield02_10h_mitotic_selectionCell line (HeLa cell cycle*), Epithelial cell line (HeLa cell cycle*), HeLa cell line (HeLa cell cycle*), Cancer and cell line (HeLa cell cycle*)